Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection - Epidemiology Insights to 2025

Publisher Name :
Date: 28-Jul-2017
No. of pages: 40
Price : Single User: US $ 2950  US $ 2360 Corporate User: US $ 8850  US $ 5310
This report is available at 20% Discount for Single User License and 40% Discount for Corporate Users License till 31 December 2017. To avail discount please contact at +1-888-391-5441 / sales@rnrmarketresearch.com.
Delivery of the Report will take 2-3 working days once order is placed.

DelveInsight's "Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection -Epidemiology Forecast, 2025" provides an overview of the epidemiology trends of Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection in seven major markets (US, France, Germany, Italy, Spain, UK and Japan). It includes 10 years epidemiology historical and forecasted data of Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection. The Report also discusses the prevailing risk factors, disease burden with special emphasis on the unmet medical needs associated with the Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection. The report contains the targeted patient populations and the forecast methodology.

The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house Forecast model analysis by DelveInsight team of industry experts.

Key Coverage and Benefits

  • The Report includes the prevalent population and how will it change over the next eight years.

  • Coverage of key Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection sub-populations and its prevalent or incident cases

  • Prevalent or incident cases segmented by age and sex.

  • The key differences in epidemiology patterns across the seven market segments.

Reasons to buy

  • Developing business strategies by understanding the trends shaping and driving the global Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection market.

  • Identifying prevalent patient populations as well as risk factors in the global Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection market will help to improve product design, pricing, and launch plans.

  • Organize sales and marketing efforts by identifying the best opportunities for Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection therapeutics in each of the markets covered.

This report is available at 20% Discount for Single User License and 40% Discount for Corporate Users License till 31 December 2017. To avail discount please contact at +1-888-391-5441 / sales@rnrmarketresearch.com.

Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection - Epidemiology Insights to 2025

Table of Contents

1. Report Introduction

2. Snapshot of Total Prevalent or Incident cases by 7 MM

3. Executive Summary
Key Findings

4. Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Overview
Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Definition
Pathophysiology
Symptoms
Etiology

5. Risk Factors Associated with Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection

6. Disease Burden & Unmet Need in the Market

7. Epidemiology and Patient Populations
Key Findings
Key Sources used and Forecast Methodology
Prevalent Cases and Incident Cases-2015-2025
Prevalent & Incident Cases by Category-2015-2025
Age-Specific Prevalent/ Incident Cases of Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection
Sex-Specific Prevalent/Incident Cases of Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection
Disease Type Specific Prevalent/Incident Cases of Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection

8.Prevalent & Incident Cases by 7 MM-2015-2025
Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Epidemiology of United States-2025
Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Epidemiology of United Kingdom-2025
Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Epidemiology of Germany-2025
Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Epidemiology of France-2025
Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Epidemiology of Spain-2025
Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Epidemiology of Italy-2025
Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Epidemiology of Japan-2025

9. Key Takeaways

10. Appendix

11.Report Methodology

12. Consulting Services

13. Disclaimer

14. About Us

List of Tables

Table 1: Clinical subtypes of Indication
Table 2: Risk Factors
Table 3: Prevalence cases (%) Region wise
Table 4: Sources used for forecasting the data
Table 5: Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Global Epidemiology, (2015-2025)
Table 6: Prevalent Cases of Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection (Ages =XX Years), US (2015-2025)
Table 7: Prevalent Cases of Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection By Sex (Males & Females), US (2015-2025)
Table 8: Prevalent Cases By Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Sub-population, US (2015-2025)
Table 9: Prevalent Cases of Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection (Ages =XX Years), United Kingdom (2015-2025)
Table 10: Prevalent Cases of Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection By Sex (Males & Females), United Kingdom (2015-2025)
Table 11: Prevalent Cases By Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Sub-population, United Kingdom (2015-2025)
Table 12: Prevalent Cases of Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection (Ages =XX Years), Germany (2015-2025)
Table 13: Prevalent Cases of Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection By Sex (Males & Females), Germany (2015-2025)
Table 14: Prevalent Cases By Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Sub-population, Germany (2015-2025)
Table 15: Prevalent Cases of Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection (Ages =XX Years), France (2015-2025)
Table 16: Prevalent Cases of Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection By Sex (Males & Females), France (2015-2025)
Table 17: Prevalent Cases By Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Sub-population, France (2015-2025)
Table 18: Prevalent Cases of Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection (Ages =XX Years), Italy (2015-2025)
Table 19: Prevalent Cases of Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection By Sex (Males & Females), Italy (2015-2025)
Table 20: Prevalent Cases By Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Sub-population, Italy (2015-2025)
Table 21: Prevalent Cases of Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection (Ages =XX Years), Spain (2015-2025)
Table 22: Prevalent Cases of Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection By Sex (Males & Females), Spain (2015-2025)
Table 23: Prevalent Cases By Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Sub-population, Spain (2015-2025)
Table 24: Prevalent Cases of Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection (Ages =XX Years), Japan (2015-2025)
Table 25: Prevalent Cases of Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection By Sex (Males & Females), Japan (2015-2025)
Table 26: Prevalent Cases By Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Sub-population, Japan (2015-2025)

List of Figures

Figure 1: Prevalence cases (%) Region wise
Figure 2: Sources used for forecasting the data
Figure 3: Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Global Epidemiology, (2015-2025)
Figure 4: Prevalent Cases of Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection (Ages =XX Years), US (2015-2025)
Figure 5: Prevalent Cases of Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection By Sex (Males & Females), US (2015-2025)
Figure 6: Prevalent Cases By Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Sub-population,US (2015-2025)
Figure 7: Prevalent Cases of Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection (Ages =XX Years), United Kingdom (2015-2025)
Figure 8: Prevalent Cases of Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection By Sex (Males & Females), United Kingdom (2015-2025)
Figure 9: Prevalent Cases By Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Sub-population,United Kingdom (2015-2025)
Figure 10: Prevalent Cases of Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection (Ages =XX Years), Germany (2015-2025)
Figure 11: Prevalent Cases of Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection By Sex (Males & Females), Germany (2015-2025)
Figure 12: Prevalent Cases By Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Sub-population,Germany (2015-2025)
Figure 13: Prevalent Cases of Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection (Ages =XX Years), France (2015-2025)
Figure 14: Prevalent Cases of Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection By Sex (Males & Females), France (2015-2025)
Figure 15: Prevalent Cases By Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Sub-population,France (2015-2025)
Figure 16: Prevalent Cases of Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection (Ages =XX Years), Italy (2015-2025)
Figure 17: Prevalent Cases of Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection By Sex (Males & Females), Italy (2015-2025)
Figure 18: Prevalent Cases By Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Sub-population,Italy (2015-2025)
Figure 19: Prevalent Cases of Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection (Ages =XX Years), Spain (2015-2025)
Figure 20: Prevalent Cases of Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection By Sex (Males & Females), Spain (2015-2025)
Figure 21: Prevalent Cases By Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Sub-population,Spain (2015-2025)
Figure 22: Prevalent Cases of Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection (Ages =XX Years), Japan (2015-2025)
Figure 23: Prevalent Cases of Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection By Sex (Males & Females), Japan (2015-2025)
Figure 24: Prevalent Cases By Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Sub-population,Japan (2015-2025)
  • Global Bovine Respiratory Disease Treatment Market Research Report 2017
    Published: 11-Dec-2017        Price: US 2900 Onwards        Pages: 110
    In this report, the global Bovine Respiratory Disease Treatment market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Bovine Respiratory Disease Treatment in these regions, from 2012 to 2022 (forecast), covering - North America......
  • Global Carbocisteine Market Data Survey Report 2025
    Published: 30-Nov-2017        Price: US 1500 Onwards        Pages: 82
    Summary Carbocisteine (INN), also called carbocysteine (USAN), is a mucolytic that reduces the viscosity of sputum and so can be used to help relieve the symptoms of chronic obstructive pulmonary disorder (COPD) and bronchiectasis by allowing the sufferer to bring up sputum more easily. Carbocisteine should not be used with antitussives (cough suppressants) or medicines that dry up bronchial secretions. The global Carbocisteine market will reach Volume Million USD i......
  • Global and Regional Carbocisteine Market Research Report 2017
    Published: 27-Nov-2017        Price: US 3500 Onwards        Pages: 152
    Summary Carbocisteine (INN), also called carbocysteine (USAN), is a mucolytic that reduces the viscosity of sputum and so can be used to help relieve the symptoms of chronic obstructive pulmonary disorder (COPD) and bronchiectasis by allowing the sufferer to bring up sputum more easily. Carbocisteine should not be used with antitussives (cough suppressants) or medicines that dry up bronchial secretions. Market Segment as follows: By Region - As......
  • Global and China Carbocisteine Market Research by Company, Type & Application 2013-2025
    Published: 20-Nov-2017        Price: US 2000 Onwards        Pages: 98
    Summary Carbocisteine (INN), also called carbocysteine (USAN), is a mucolytic that reduces the viscosity of sputum and so can be used to help relieve the symptoms of chronic obstructive pulmonary disorder (COPD) and bronchiectasis by allowing the sufferer to bring up sputum more easily. Carbocisteine should not be used with antitussives (cough suppressants) or medicines that dry up bronchial secretions. Market Segment as follows: By Type - 0.98......
  • Global Carbocisteine Market Research Report 2011-2023
    Published: 17-Nov-2017        Price: US 1800 Onwards        Pages: 83
    Summary Carbocisteine (INN), also called carbocysteine (USAN), is a mucolytic that reduces the viscosity of sputum and so can be used to help relieve the symptoms of chronic obstructive pulmonary disorder (COPD) and bronchiectasis by allowing the sufferer to bring up sputum more easily. Carbocisteine should not be used with antitussives (cough suppressants) or medicines that dry up bronchial secretions. The global Carbocisteine market will reach xxx Million USD in 2......
  • Respiratory Syncytial Virus (RSV) Infections - Pipeline Review, H2 2017
    Published: 14-Nov-2017        Price: US 2000 Onwards        Pages: 255
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Respiratory Syncytial Virus (RSV) Infections - Pipeline Review, H2 2017, provides an overview of the Respiratory Syncytial Virus (RSV) Infections (Infectious Disease) pipeline landscape. Respiratory syncytial virus (RSV) infection is a respiratory disease. It infects the lungs and breathing passages. RSV commonly causes bronchiolitis (inflammation of the small airways in the lung) and pneumonia in ......
  • Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection - Market Insights, Epidemiology and Market Forecast - 2025
    Published: 01-Nov-2017        Price: US 5750 Onwards        Pages: 70
    DelveInsight's "Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection - Market Insights, Epidemiology and Market Forecast - 2025" report provides an overview of the disease and in depth research related to Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection for the 7MM (United States, Germany, France, Italy, Spain and UK) for the study period undertaken from 2015-2025. This report provides understanding of the patients affected, diagnosed patterns, treatment trends, unmet med......
  • Sleep Apnea - Market Insights, Epidemiology and Market Forecast - 2025
    Published: 01-Nov-2017        Price: US 5750 Onwards        Pages: 70
    DelveInsight's "Sleep Apnea - Market Insights, Epidemiology and Market Forecast - 2025" report provides an overview of the disease and in depth research related to Sleep Apnea for the 7MM (United States, Germany, France, Italy, Spain and UK) for the study period undertaken from 2015-2025. This report provides understanding of the patients affected, diagnosed patterns, treatment trends, unmet medical needs and current developments for Sleep Apnea . It enables understanding of the historical and f......
  • Global Respiratory Partnering 2010-2017: Deal trends, players and financials
    Published: 01-Nov-2017        Price: US 2995 Onwards        Pages: 800
    "Delivery of this report will take 1-3 days after purchase." Global Respiratory Partnering 2010 to 2017 provides the full collection of Respiratory disease deals signed between the world's pharmaceutical and biotechnology companies since 2010. Trends in Respiratory partnering deals Financial deal terms for headline, upfront and royalty by stage of development Respiratory partnering agreement structure Respiratory partnering cont......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs